Thrombophilia: Blood Clotting Disorders—Types, Risks, and Management

Thrombophilia (hypercoagulable state) is an increased tendency to form abnormal blood clots, leading to deep vein thrombosis (DVT), pulmonary embolism (PE), or arterial thrombosis. It can be inherited or acquired.

Inherited Thrombophilias (Genetic)

  • Factor V Leiden: Most common (5% of Europeans). Resistance to activated protein C → increased clotting. Heterozygous: 4–8× risk; homozygous: 80× risk.
  • Prothrombin G20210A mutation: 2–3% of Europeans. Elevated prothrombin levels → 2–3× DVT risk.
  • Antithrombin deficiency: Rare, high thrombotic risk (50% by age 50). Also increases heparin resistance.
  • Protein C deficiency: Rare; risk of warfarin-induced skin necrosis.
  • Protein S deficiency: Similar to protein C; hormonal triggers (pregnancy, oral contraceptives) increase risk.

Note: Thrombocytopenia (low platelets) is a bleeding risk, not thrombophilia—excluded from this list.

Acquired Thrombophilias

  • Antiphospholipid syndrome (APS): Autoimmune; arterial and venous clots, pregnancy loss. Diagnosed by lupus anticoagulant, anticardiolipin, and anti-β2-glycoprotein I antibodies.
  • Cancer (especially adenocarcinoma, pancreatic, brain): Procoagulant state.
  • Pregnancy and postpartum: Physiological hypercoagulability.
  • Hormonal therapy: Combined oral contraceptives (estrogen), hormone replacement therapy.
  • Surgery, trauma, immobility: Situational triggers.
  • Nephrotic syndrome, inflammatory bowel disease, myeloproliferative neoplasms.

Who Should Be Tested?

  • Unprovoked VTE before age 50
  • Recurrent VTE
  • VTE in unusual sites (cerebral, portal, mesenteric veins)
  • Family history of VTE (first-degree relative before age 50)
  • Recurrent pregnancy loss (APS workup)
  • Before estrogen therapy in high-risk women

Management

  • Asymptomatic carriers: Usually no anticoagulation; counsel on situational prophylaxis (surgery, travel, pregnancy).
  • Prior VTE: Anticoagulation duration based on provoked vs. unprovoked, bleeding risk, patient preference.
  • Pregnancy: Prophylactic low-molecular-weight heparin for most inherited thrombophilias; therapeutic for APS or history of VTE.
  • Estrogen avoidance: Use progestin-only or non-hormonal contraception in thrombophilia.

Consult a hematologist for personalized risk assessment and management.

Blood Disorders - Related Articles